Haemolytic Uraemic Syndrome and Its Relation to Metastatic Prostate Adenocarcinoma: A Case Report

Le résumé fourni par la source

Haemolytic Uraemic Syndrome (HUS) has been rarely related to prostate cancer. The few cases reported in the literature show a better prognosis with the implementation of oncologic treatment. Its pathogenesis is unknown and has never been described as a consequence of treatment with bicalutamide. At the presented case this association couldn’t be dismissed due to its temporal relationship, so surgical castration was carried out. it is important to recognize signs and symptoms of HUS on time because an early intervention is related to a better outcome.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.